People

Search Language

中文(中国) / Simplified Chinese | Use language selector above (below, on mobile) to search additional languages
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  • Search
  • Selected filters
  • x(the)
  • x(http://www.example.com)
  • x(Boston)
  • clear all

72 items matching filters

Search Results

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Chapin Scaggs 主理律师

Boston

Chapin focuses on representing high-growth technology companies of all sizes throughout their life-cycles-- from general formation and corporate governance through to venture capital and private equity financings.  He also advises investors and venture capital firms in their investments in early and high growth technology companies.

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Chapin Scaggs 主理律师

Boston

Chapin focuses on representing high-growth technology companies of all sizes throughout their life-cycles-- from general formation and corporate governance through to venture capital and private equity financings.  He also advises investors and venture capital firms in their investments in early and high growth technology companies.

448119

Practice:

  • Life Sciences & HealthTech
  • Technology Transactions
  • Technology Companies Group
  • Private Equity
  • Mergers & Acquisitions
  • Strategic Advisory & Government Enforcement (SAGE)

David Sharrow 合伙人

Boston

David brings a wealth of expertise, focusing on diverse cutting-edge technologies, including life sciences (biotechnology, pharmaceuticals, medical devices, digital health, genomic technology), fintech, artificial intelligence, information technology (hardware, software, SaaS, and database solutions), edtech, renewable energy, sustainable technologies, AR/VR and cybersecurity.

He advises clients on corporate partnerships, strategic alliances and licensing agreements with leading U.S. and global entities, as well as major research universities and institutes. His experience includes navigating the IP and technology aspects of venture capital financings, public offerings and some of the largest M&A transactions involving venture-backed companies.

David has lectured at major institutions, including Tulane, Yale, Princeton, NYU, Columbia, Cornell and Fordham.

448119

Practice:

  • Life Sciences & HealthTech
  • Technology Transactions
  • Technology Companies Group
  • Private Equity
  • Mergers & Acquisitions
  • Strategic Advisory & Government Enforcement (SAGE)

David Sharrow 合伙人

Boston

David brings a wealth of expertise, focusing on diverse cutting-edge technologies, including life sciences (biotechnology, pharmaceuticals, medical devices, digital health, genomic technology), fintech, artificial intelligence, information technology (hardware, software, SaaS, and database solutions), edtech, renewable energy, sustainable technologies, AR/VR and cybersecurity.

He advises clients on corporate partnerships, strategic alliances and licensing agreements with leading U.S. and global entities, as well as major research universities and institutes. His experience includes navigating the IP and technology aspects of venture capital financings, public offerings and some of the largest M&A transactions involving venture-backed companies.

David has lectured at major institutions, including Tulane, Yale, Princeton, NYU, Columbia, Cornell and Fordham.

467366

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Reilly Clark 主理律师

Boston

Reilly focuses on representing  high growth technology and life sciences companies through their business life cycle. He advises on a broad range of corporate and transactional matters from formation to exit, including incorporation, governance, financing, and M&A matters. Reilly regularly counsels clients on both venture capital transactions as well as day-to-day governance and equity compensation matters.

Prior to joining Orrick, Reilly worked with Wilson Sonsini Goodrich & Rosati in its Boston office and served in the United States Marine Corps.

467366

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Reilly Clark 主理律师

Boston

Reilly focuses on representing  high growth technology and life sciences companies through their business life cycle. He advises on a broad range of corporate and transactional matters from formation to exit, including incorporation, governance, financing, and M&A matters. Reilly regularly counsels clients on both venture capital transactions as well as day-to-day governance and equity compensation matters.

Prior to joining Orrick, Reilly worked with Wilson Sonsini Goodrich & Rosati in its Boston office and served in the United States Marine Corps.

465979

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group
  • Life Sciences & HealthTech

Mark Solakian 合伙人

Boston

With more than three decades of experience advising both private and public companies—and having served as a senior in-house executive across multiple pioneering biotech and life sciences companies—Mark brings a uniquely business minded perspective to his counsel and delivers a rare blend of legal acumen and executive experience that positions him as a trusted strategic partner to entrepreneurs, companies and investors.

Mark is a veteran of hundreds of successful venture capital financings, technology and licensing transactions, strategic alliances, corporate governance matters, mergers and acquisitions, and public and private equity and debt offerings on behalf of companies in every health and biotech related vertical.

Before joining Orrick, Mark was a partner and co-founder of the Wilson Sonsini Boston office. He previously held senior executive roles at Affymetrix (AFFX), Helicos Biosciences (HLCS) and Joule Global Holdings, where he oversaw legal strategy, led public offerings and financings, negotiated strategic partnerships and licensing transactions, and managed critical business functions including HR, finance, and government affairs.

Mark and his wife, Christine, have been married for more than 25 years and have two adult children.

465979

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group
  • Life Sciences & HealthTech

Mark Solakian 合伙人

Boston

With more than three decades of experience advising both private and public companies—and having served as a senior in-house executive across multiple pioneering biotech and life sciences companies—Mark brings a uniquely business minded perspective to his counsel and delivers a rare blend of legal acumen and executive experience that positions him as a trusted strategic partner to entrepreneurs, companies and investors.

Mark is a veteran of hundreds of successful venture capital financings, technology and licensing transactions, strategic alliances, corporate governance matters, mergers and acquisitions, and public and private equity and debt offerings on behalf of companies in every health and biotech related vertical.

Before joining Orrick, Mark was a partner and co-founder of the Wilson Sonsini Boston office. He previously held senior executive roles at Affymetrix (AFFX), Helicos Biosciences (HLCS) and Joule Global Holdings, where he oversaw legal strategy, led public offerings and financings, negotiated strategic partnerships and licensing transactions, and managed critical business functions including HR, finance, and government affairs.

Mark and his wife, Christine, have been married for more than 25 years and have two adult children.

454522

Practice:

  • FDA & Healthcare Regulatory
  • Life Sciences & HealthTech
  • Strategic Advisory & Government Enforcement (SAGE)
  • Technology Companies Group
  • Technology & Innovation

Melania Jankowski 主理律师

Boston

Her experience includes advising on corporate practice of medicine and scope of practice issues, state licensure requirements for physicians and non-physician practitioners, controlled substance prescribing considerations, and health care privacy concerns. Melania also assists with regulatory due diligence for stakeholders interested in investments in digital health and health care technology ventures.

454522

Practice:

  • FDA & Healthcare Regulatory
  • Life Sciences & HealthTech
  • Strategic Advisory & Government Enforcement (SAGE)
  • Technology Companies Group
  • Technology & Innovation

Melania Jankowski 主理律师

Boston

Her experience includes advising on corporate practice of medicine and scope of practice issues, state licensure requirements for physicians and non-physician practitioners, controlled substance prescribing considerations, and health care privacy concerns. Melania also assists with regulatory due diligence for stakeholders interested in investments in digital health and health care technology ventures.

408599

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Andy Bloom 高级律师

Boston

Andy advises high growth technology companies, startup founders, private funds and other institutional investors on a broad range of corporate transactions across industries. He has extensive experience in a broad range of corporate and transactional matters, advising companies from formation to exit on formation, governance, and financing matters, and private funds and institutional investors on venture capital, growth equity and private equity investments. Andy works closely with clients to provide strategic insights and outside general counsel services, advising clients on day-to-day governance, equity compensation and general commercial matters.

Andy also has extensive experience advising sponsors of private investment funds on their formation, regulatory compliance, and fundraising activities, as well as institutional investors in connection with various aspects of their investment programs, including investments in private investment funds, co-investments and complex secondaries transactions.

408599

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Andy Bloom 高级律师

Boston

Andy advises high growth technology companies, startup founders, private funds and other institutional investors on a broad range of corporate transactions across industries. He has extensive experience in a broad range of corporate and transactional matters, advising companies from formation to exit on formation, governance, and financing matters, and private funds and institutional investors on venture capital, growth equity and private equity investments. Andy works closely with clients to provide strategic insights and outside general counsel services, advising clients on day-to-day governance, equity compensation and general commercial matters.

Andy also has extensive experience advising sponsors of private investment funds on their formation, regulatory compliance, and fundraising activities, as well as institutional investors in connection with various aspects of their investment programs, including investments in private investment funds, co-investments and complex secondaries transactions.